Synthesis and characterization of an injectable rifampicin-loaded chitosan/hydroxyapatite bone cement for drug delivery
Source abstract
Abstract
Rifampicin (RFP) is a first-line hydrophobic anti-tuberculosis drug. An injectable RFP-loaded cement was prepared as a bone scaffold and drug delivery vehicle in this paper. The samples were characterized by scanning electron microscope (SEM), Fourier transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD). The injection performance, compressive strength, degradation performance, cytotoxicity, and in vitro release of the drug-loaded cement were evaluated as well. Moreover, the effects of RFP on the properties of cement were discussed. The results showed that the cement had an appropriate setting time and good injectability to meet the clinical requirements for bone defect repair. RFP had no significant effect on the setting time of cement. But RFP increased the porosity of the cement and reduced its strength. The in vitro drug release studies demonstrated that the RFP-loaded cement had a good sustained release effect on RFP. It had great potential as a drug-loaded artificial bone material for bone repair and anti-tuberculosis.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. F.C.F. Santos, A.L.A. Nascimento, L.A.S. Lira, J.F.C. Lima, R.A. Montenegro, L.M.L. Montenegro, H.C. Schindler, Bone tuberculosis: a case report on child. Rev. Soc. Bras. Med. Trop. 46, 249 (2013)10.1590/0037-8682-0010-2012 ↗
2. R.A. Praphakar, M. Sumathra, R.S. Ebenezer, S. Vignesh, H. Shakila, M. Rajan, Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration. Int. J. Pharm. 565, 543 (2019)10.1016/j.ijpharm.2019.05.035 ↗
3. M. Zhu, K. Li, Y.F. Zhu, J.H. Zhang, X.J. Ye, 3D-printed hierarchical scaffold for localized isoniazid/rifampin drug delivery and osteoarticular tuberculosis therapy. Acta Biomater. 16, 145 (2015)10.1016/j.actbio.2015.01.034 ↗
4. C.S. Liu, W.B. Wang, W. Shen, T.Y. Chen, L.M. Hu, Z.W. Chen, Evaluation of the biocompatibility of a nonceramic hydroxyapatite. J. Endod. 23, 490 (1997)10.1016/S0099-2399(97)80307-X ↗
5. D.M. Lawton, M.D.J. Lamaletie, D.L. Gardner, Biocompatibility of hydroxyapatite ceramic: response of chondrocytes in a test system using low temperature scanning electron microscopy. J. Dent. 17, 21 (1989)10.1016/0300-5712(89)90003-1 ↗
6. G.T. Craig, I.M. Brook, D.J. Lamb, Tissue response to subperiosteal implantation of dense hydroxyapatite: case report. Biomaterials 10, 133 (1989)10.1016/0142-9612(89)90047-1 ↗
7. M. Lind, S. Overgaard, C. Bünger, K. Søballe, Improved bone anchorage of hydroxyapatite coated implants compared with tricalcium-phosphate coated implants in trabecular bone in dogs. Biomaterials 20, 803 (1999)10.1016/S0142-9612(98)00216-6 ↗
8. X. Wang, L.R. Liu, Q.Q. Zhang, A study on nano-hydroxyapatite-chitosan scaffold for bone tissue engineering. Chin. J. Repar. Reconstr. Surg. 21, 120 (2007). ((in Chinese))
9. T. Kasuga, Y. Ota, M. Nogami, Y. Abe, Preparation and mechanical properties of polylactic acid composites containing hydroxyapatite fibers. Biomaterials 22, 19 (2000)10.1016/S0142-9612(00)00091-0 ↗
10. M.W. Laschke, A. Strohe, M.D. Menger, M. Alini, D. Eglin, In vitro and in vivo evaluation of a novel nanosized hydroxyapatite particles/poly(ester-urethane) composite scaffold for bone tissue engineering. Acta Biomater. 6, 2020 (2010)10.1016/j.actbio.2009.12.004 ↗
11. C.V.M. Rodrigues, P. Serricella, A.B.R. Linhares, R.M. Guerdes, R. Borojevic, M.A. Rossi, M.E.L. Duarte, M. Farina, Characterization of a bovine collagen-hydroxyapatite composite scaffold for bone tissue engineering. Biomaterials 24, 4987 (2003)10.1016/S0142-9612(03)00410-1 ↗
12. I.M. Pelin, S.S. Maier, G.C. Chitanu, V. Bulacovschi, Preparation and characterization of a hydroxyapatite-collagen composite as component for injectable bone substitute. Mater. Sci. Eng. C 29, 2188 (2009)10.1016/j.msec.2009.04.021 ↗
13. J.J. Li, Y.J. Yin, F.L. Yao, L.L. Zhang, K.D. Yao, Effect of nano-and micro-hydroxyapatite/chitosan-gelatin network film on human gastric cancer cells. Mater. Lett. 62, 3220 (2008)10.1016/j.matlet.2008.02.072 ↗
14. M. Kong, X.G. Chen, K. Xing, H.J. Park, Antimicrobial properties of chitosan and mode of action: a state of the art review. Int. J. Food Microbiol. 144, 51 (2010)10.1016/j.ijfoodmicro.2010.09.012 ↗
15. Y. Hong, H.Q. Song, Y.H. Gong, Z.W. Mao, C.Y. Gao, J.C. Shen, Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation. Acta Biomater. 3, 23 (2007)10.1016/j.actbio.2006.06.007 ↗
16. P.R. Klokkevold, D.S. Lew, D.G. Ellis, C.N. Bertolami, Effect of chitosan on lingual hemostasis in rabbits. J. Oral. Maxillofac. Surg. 49, 858 (1991)10.1016/0278-2391(91)90017-G ↗
17. P.L. Kang, S.J. Chang, I. Manousakas, C.W. Lee, C.H. Yao, F.H. Lin, S.M. Kuo, Development and assessment of hemostasis chitosan dressings. Carbohydr. Polym. 85, 565 (2011)10.1016/j.carbpol.2011.03.015 ↗
18. M.N.V.R. Kumar, A review of chitin and chitosan applications. React. Funct. Polym. 46, 1 (2000)10.1016/S1381-5148(00)00038-9 ↗
19. W. Paul, C.P. Sharma, Chitosan, a drug carrier for the 21st century: a review. STP Pharm Sci. 10, 5 (2000)
20. O. Felt, P. Buri, R. Gurny, Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24, 979 (1998)10.3109/03639049809089942 ↗
21. A. Karakeçili, B. Topuz, S. Korpayev, M. Erdek, Metal-organic frameworks for on-demand pH controlled delivery of vancomycin from chitosan scaffolds. Mater. Sci. Eng. C 105, 110098 (2019)10.1016/j.msec.2019.110098 ↗
22. M. Dash, F. Chiellini, R.M. Ottenbrite, E. Chiellini, Chitosan—a versatile semisynthetic polymer in biomedical applications. Prog. Polym. Sci. 36, 981 (2011)10.1016/j.progpolymsci.2011.02.001 ↗
23. F. Chellat, M. Tabrizian, S. Dumitriu, E. Chornet, C.H. Rivard, L. Yahia, Study of biodegradation behavior of chitosan-xanthan microspheres in simulated physiological media. J. Biomed. Mater. Res. Part A 53, 592 (2000)10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P ↗
24. W.S. Xia, P. Liu, J.L. Zhang, J. Chen, Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloids 25, 170 (2011)10.1016/j.foodhyd.2010.03.003 ↗
25. J. Klinkaewnarong, E. Swatsitang, S. Maensiri, Nanocrystalline hydroxyapatite powders by a chitosan–polymer complex solution route: Synthesis and characterization. Solid State Sci. 11, 1023 (2009)10.1016/j.solidstatesciences.2009.02.003 ↗
26. L.J. Kong, Y. Gao, G.Y. Lu, Y.D. Gong, N.M. Zhao, X.F. Zhang, A study on the bioactivity of chitosan/nano-hydroxyapatite composite scaffolds for bone tissue engineering. Eur. Polym. J. 42, 3171 (2006)10.1016/j.eurpolymj.2006.08.009 ↗
27. T. Kawakami, M. Antoh, H. Hasegawa, T. Yamagishi, M. Ito, S. Eda, Experimental study on osteoconductive properties of a chitosan-bonded hydroxyapatite self-hardening paste. Biomaterials 13, 759 (1992)10.1016/0142-9612(92)90014-F ↗
28. Q.L. Hu, B.Q. Li, M. Wang, J.C. Shen, Preparation and characterization of biodegradable chitosan/hydroxyapatite nanocomposite rods via in situ hybridization: a potential material as internal fixation of bone fracture. Biomaterials 25, 779 (2004)10.1016/S0142-9612(03)00582-9 ↗
29. S.H. Teng, E.J. Lee, P. Wang, S.H. Jun, C.M. Han, H.E. Kim, Functionally gradient chitosan/hydroxyapatite composite scaffolds for controlled drug release. J. Biomed. Mater. Res. Part B 90B, 275 (2009)10.1002/jbm.b.31283 ↗
30. S. Saravanan, S. Nethala, S. Pattnaik, A. Tripathi, A. Moorthi, N. Selvamurugan, Preparation, characterization and antimicrobial activity of a bio-composite scaffold containing chitosan/nano-hydroxyapatite/nano-silver for bone tissue engineering. Int. J. Biol. Macromol. 49, 188 (2011)10.1016/j.ijbiomac.2011.04.010 ↗
31. B. Xue, C. Zhang, Y.H. Wang, J.C. Wang, J.E. Zhang, M. Lu, G.D. Li, Z.Z. Cao, Q.S. Huang, A novel controlled-release system for antibacterial enzyme lysostaphin delivery using hydroxyapatite/chitosan composite bone cement. PLoS ONE 9, e113797 (2014)10.1371/journal.pone.0113797 ↗
32. D. He, P. Deng, L. Yang, Q.Y. Tan, J. Liu, M. Yang, J.Q. Zhang, Molecular encapsulation of rifampicin as an inclusion complex of hydroxypropyl–cyclodextrin: design; characterization and in vitro dissolution. Colloids Surf. B 103, 580 (2013)10.1016/j.colsurfb.2012.10.062 ↗
33. M. Grobbelaar, G.E. Louw, S.L. Sampson, P.D. Helden, P.R. Donald, R.M. Warren, Evolution of rifampicin treatment for tuberculosis. Infect. Genet. Evol. 74, 103937 (2019)10.1016/j.meegid.2019.103937 ↗
34. J.A.S. Mulla, M. Mabrouk, Y.E. Choonara, P. Kumar, D.R. Chejara, L.C. Toit, V. Pillay, Development of respirable rifampicin-loaded nano-lipomer composites by microemulsion-spray drying for pulmonary delivery. J. Drug Deliv. Sci. Technol. 41, 13 (2017)10.1016/j.jddst.2017.06.017 ↗
35. J.H. Wu, Z. Ding, Q. Lei, M. Li, Y. Liang, T. Lu, An experimental study on a slow-release complex with rifampicin-polylactic-co-glycolic acid-calcium phosphate cement. J. Cent. South Univ. Med. Sci. 41, 946 (2016). ((in Chinese))
36. J. Aragón, S. Feoli, S. Irusta, G. Mendoza, Composite scaffold obtained by electro-hydrodynamic technique for infection prevention and treatment in bone repair. Int. J. Pharm. 557, 162 (2019)10.1016/j.ijpharm.2018.12.002 ↗
37. K.L. Low, S.H. Tan, S.H.S. Zein, J.A. Roether, V. Mouriño, A.R. Boccaccini, Calcium phosphate-based composites as injectable bone substitute materials. J. Biomed. Mater. Res. Part B. 94B, 273 (2010)10.1002/jbm.b.31619 ↗
38. D. Pooja, L. Tunki, H. Kulhari, B.B. Reddy, R. Sistla, Characterization, biorecognitive activity and stability of WGA grafted lipid nanostructures for the controlled delivery of Rifampicin. Chem. Phys. Lipids. 193, 11 (2015)10.1016/j.chemphyslip.2015.09.008 ↗
39. A. Favila, M. Gallo, D. Glossman-Mitnik, CHIH-DFT determination of the molecular structure infrared spectra, UV spectra and chemical reactivity of three antitubercular compounds: rifampicin, isoniazid and pyrazinamide. J. Mol. Model. 13, 505 (2007)10.1007/s00894-007-0170-2 ↗
40. Y.G. Bi, Z.T. Lin, S.T. Deng, Fabrication and characterization of hydroxyapatite/sodium alginate/chitosan composite microspheres for drug delivery and bone tissue engineering. Mater. Sci. Eng. C 100, 576 (2019)10.1016/j.msec.2019.03.040 ↗
41. T. Başargan, G. Nasün-Saygılı, Spray-dried mesoporous hydroxyapatite–chito-san biocomposites. Polym.-Plast. Technol. Eng. 54, 1172 (2015)10.1080/03602559.2014.1003235 ↗
42. R.X. Li, C. Xu, Y.J. Liu, H. Li, C.H. Shi, W.H. Su, W.N. An, Y.H. Yuan, X.L. Qin, Y.Q. Xu, X.Z. Zhang, H. Li, Degradation behavior and compatibility of micro, nanoHA/chitosan scaffolds with interconnected spherical macropores. Int. J. Biol. Macromol. 103, 385 (2017)10.1016/j.ijbiomac.2017.03.175 ↗
43. T. Basargan, N. Erdol-Aydin, G. Nasun-Saygili, Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies. J Mater Sci: Mater. Med. 28, 180 (2017)
44. H.G. Chen, S.L. Leng, Rapid synthesis of hollow nano-structured hydroxyapatite microspheres via microwave transformation method using hollow CaCO3 precursor microspheres. Ceram. Int. 41, 2209 (2015)10.1016/j.ceramint.2014.10.021 ↗
45. H.X. Zhao, H. Jin, J.Y. Cai, Preparation and characterization of nano-hydroxyapatite/chitosan composite with enhanced compressive strength by urease-catalyzed method. Mater. Lett. 116, 293 (2014)10.1016/j.matlet.2013.05.082 ↗
46. Q. Zou, Y.B. Li, L. Zhang, Y. Zuo, J.F. Li, J.D. Li, Antibiotic delivery system using nano-hydroxyapatite/chitosan bone cement consisting of berberine. J. Biomed. Mater. Res. Part A 89A, 1108 (2009)10.1002/jbm.a.32199 ↗
47. J.F. Li, Y.Q. Liu, Y. Gao, L.Z. Zhong, Q. Zou, X.F. Lai, Preparation and properties of calcium citrate nanosheets for bone graft substitute. Bioengineered 5, 376 (2015)
48. H. Chen, M.Z. Ji, Z.W. Ding, Y.G. Yan, Vitamin D3-loaded calcium citrate/calcium sulfate composite cement with enhanced physicochemical properties, drug release, and cytocompatibility. J. Biomater. Appl. 34, 1343–1354 (2020)10.1177/0885328220904498 ↗
49. L.M. Wang, W. Wang, X.C. Li, L. Peng, Z.Q. Lin, H.Z. Xü, Calcium citrate: a new biomaterial that can enhance bone formation in situ. Chin. J. Traumatol. 15, 291 (2012)
50. I.T. Zedan, E.M. El-Menyawy, A.M. Mansour, Physical characterizations of 3-(4-methyl piperazinylimino methyl) rifampicin films for photodiode applications. Silicon 11, 1693 (2019)10.1007/s12633-018-9989-7 ↗
51. X. Cai, L. Chen, T. Jiang, X.Y. Shen, J.M. Hu, H. Tong, Facile synthesis of anisotropic porous chitosan/hydroxyapatite scaffolds for bone tissue engineering. J. Mater. Chem. 21, 12015 (2011)10.1039/c1jm11503k ↗
52. S.S. Liao, F.Z. Cui, W. Zhang, Q.L. Feng, Hierarchically biomimetic bone scaffold materials: Nano-HA/collagen/PLA composite. J. Biomed. Mater. Res. Part B 69B, 158 (2004)10.1002/jbm.b.20035 ↗
53. Z. Huang, Q.L. Feng, B. Yu, S.J. Li, Biomimetic properties of an injectable chitosan/nano-hydroxyapatite/collagen composite. Mater. Sci. Eng. C 31, 683 (2011)10.1016/j.msec.2010.12.014 ↗
54. B. Ma, Z.G. Huan, C. Xu, N. Ma, H.B. Zhu, J.P. Zhong, J. Chang, Preparation and in vivo evaluation of a silicate-based composite bone cement. J. Biomater. Appl. 32, 257 (2017)10.1177/0885328217715428 ↗
55. Y.F. Su, C.C. Lin, T.H. Huang, M.Y. Chou, J.J. Yang, M.Y. Shie, Osteogenesis and angiogenesis properties of dental pulp cell on novel injectable tricalcium phosphate cement by silica doped. Mater. Sci. Eng. C 42, 672 (2014)10.1016/j.msec.2014.05.038 ↗
56. Y. Shu, F. Qiu, Y. Zhang, W.J. Cao, Z.N. Wu, S.J. Nian, N.Y. Zhou, Novel vaterite-containing tricalcium silicate bone cement by surface functionalization using 3-aminopropyltriethoxysilane: setting behavior, in vitro bioactivity and cytocompatibility. Biomed. Mater. 12, 065007 (2017)10.1088/1748-605X/aa84b8 ↗
57. L.L. Hench, Bioceramics: from concept to clinic. J. Am. Ceram. Soc. 74, 1487 (1991)10.1111/j.1151-2916.1991.tb07132.x ↗
58. U. Tariq, R. Hussain, K. Tufail, Z. Haider, R. Tariq, J. Ali, Injectable dicalcium phosphate bone cement prepared from biphasic calcium phosphate extracted from lamb bone. Mater. Sci. Eng. C 103, 109863 (2019)10.1016/j.msec.2019.109863 ↗
59. I.T. Wu, P.F. Kao, Y.R. Huang, S.J. Ding, In vitro and in vivoosteogenesis of gelatin-modified calcium silicate cement with washout resistance. Mater. Sci. Eng. C 117, 111297 (2020)10.1016/j.msec.2020.111297 ↗
60. H.X. Zhao, Effect of glutaraldehyde cross-linking on the properties of chitosan/hydroxyapatite-gentamicin delayed materials. Chin. J. Tissue Eng. Res. 18, 4783 (2014). ((in Chinese))
61. T. Schön, P. Juréen, C.G. Giske, E. Chryssanthou, E. Sturegård, J. Werngren, G. Kahlmeter, S.E. Hoffner, K.A. Ängeby, Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. J. Antimicrob. Chemother. 64, 786 (2009)10.1093/jac/dkp262 ↗
62. B.K.B. Uchoa, C.A.A. Albério, A.C.G. Pinto, S.M.A. Lucena, J.L.F. Vieira, Concentrations of rifampicin in pre-dose samples in patients with pulmonary tuberculosis. Braz. J. Infect. Dis. 23, 130 (2019)10.1016/j.bjid.2019.05.001 ↗
63. W.H. Liang, Z.J. Tan, S.J. Ou, H.X. Zhao, Properties of hydroxyapatite/chit- osan-naringin drug delivery systems. J. Funct. Mater. 19, 19131 (2015). ((in Chinese))
64. S. Adepu, M. Khandelwal, Ex-situ modification of bacterial cellulose for immediate and sustained drug release with insights into release mechanism. Carbohydr. Polym. 249, 116846 (2020)10.1016/j.carbpol.2020.116816 ↗
65. P.L. Ritger, N.A. Peppas, A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release 5, 37 (1987)10.1016/0168-3659(87)90035-6 ↗
66. Z.J. Pei, K.L. Zhang, P.B. Li, J.B. Zhai, G.D. Li, W.C. Shang, Zi-Ran-Tong loaded brushite bone cement with enhanced osteoblast mineralization ability in vitro. Mater. Lett. 259, 126908 (2020)10.1016/j.matlet.2019.126908 ↗
67. Y. Yu, C. Xu, H.L. Dai, Preparation and characterization of a degradable magnesium phosphate bone cement. Regener. Biomater. 3, 231 (2016)10.1093/rb/rbw024 ↗
68. C.B. Cao, H. Li, J. Li, C. Liu, H.L. Yang, B. Li, Mechanical reinforcement of injectable calcium phosphate cement/silk fibroin (SF) composite by mineralized SF. Ceram. Int. 40, 13987 (2014)10.1016/j.ceramint.2014.05.123 ↗
69. L. Chen, D. Zhai, Z.G. Huan, N. Ma, H.B. Zhu, C.T. Wu, J. Chang, Silicate bioceramic/PMMA composite bone cement with distinctive physicochemical and bioactive properties. RSC Adv. 5, 37314 (2015)10.1039/C5RA04646G ↗